Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy

Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy

Bibliographic Details
Main Authors:	Dominique O. Riddell, John C. W. Hildyard, Rachel C. M. Harron, Natasha L. Hornby, Dominic J. Wells, Richard J. Piercy
Format:	Article
Language:	English
Published:	The Company of Biologists 2022-12-01
Series:	Disease Models & Mechanisms
Subjects:	dystrophin duchenne muscular dystrophy de50-md dog model inflammatory cytokines ccl2 serum biomarker
Online Access:	http://dmm.biologists.org/content/15/12/dmm049394

Similar Items

Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy
by: Dominique O. Riddell, et al.
Published: (2023-12-01)

The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy [version 1; peer review: 2 approved]
by: Claire Massey, et al.
Published: (2022-09-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Longitudinal assessment of blood-borne musculoskeletal disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy [version 2; peer review: 2 approved]
by: John C. W. Hildyard, et al.
Published: (2022-08-01)

Promising therapeutic approaches of utrophin replacing dystrophin in the treatment of Duchenne muscular dystrophy
by: Ruo Wu, et al.
Published: (2022-11-01)

Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
by: Rasic Milic V., et al.
Published: (2014-12-01)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
by: Guiraud, S, et al.
Published: (2019)

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
by: Chengmei Sun, et al.
Published: (2020-07-01)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01)

Duchenne/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India
by: Mandava V Rao, et al.
Published: (2014-01-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Language Development in Preschool Duchenne Muscular Dystrophy Boys
by: Daniela Pia Rosaria Chieffo, et al.
Published: (2022-09-01)

Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
by: Addeli Bez Batti Angulski, et al.
Published: (2023-06-01)

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy
by: Nicolas Dubuisson, et al.
Published: (2022-12-01)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01)

Duchenne muscular dystrophy treatment with lentiviral vector containing mini‐dystrophin gene in vivo
by: Xiaoyu Wang, et al.
Published: (2024-01-01)

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter
by: Abbe H. Crawford, et al.
Published: (2023-03-01)

A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies
by: Ahlke Heydemann, et al.
Published: (2023-03-01)

Duchenne muscular dystrophy caused by a deletion (c.5021del) in exon 35 of the DMD gene: A case report and review of the literature
by: Yue Liu, et al.
Published: (2024-04-01)

The X‐linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45–47
by: Christopher R. Heier, et al.
Published: (2023-04-01)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)

Molecular Characterization of Dystrophin Gene in Iraqi Patients with Muscular Dystrophy.
by: Areen T. Ramadhan Al-Hadithi, et al.
Published: (2014-07-01)

Expression and function of four AAV-based constructs for dystrophin restoration in the mdx mouse model of Duchenne muscular dystrophy
by: Rachael A. Potter, et al.
Published: (2023-09-01)

Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
by: Kasun Kodippili, et al.
Published: (2023-05-01)

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
by: Arianna Manini, et al.
Published: (2022-01-01)

The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies
by: Woo Hyun Yoo, et al.
Published: (2017-06-01)

Ion Channels of the Sarcolemma and Intracellular Organelles in Duchenne Muscular Dystrophy: A Role in the Dysregulation of Ion Homeostasis and a Possible Target for Therapy
by: Mikhail V. Dubinin, et al.
Published: (2023-01-01)

Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
by: Fernanda Fortunato, et al.
Published: (2021-02-01)

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
by: Nicolas Wein, et al.
Published: (2022-09-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy
by: Jerry R. Mendell, et al.
Published: (2023-07-01)

A comprehensive database of Duchenne and Becker muscular dystrophy patients in Children's Hospital of Fudan University
by: Xi-hua LI, et al.
Published: (2015-05-01)

Is Electrical Stimulation Useful for Patients with Duchenne Muscular Dystrophy? A Mini-review
by: Hojjat Radinmehr, et al.
Published: (2023-04-01)

Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community
by: Nasser A. Elhawary, et al.
Published: (2018-04-01)

A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20
by: Sara Mata López, et al.
Published: (2018-05-01)

Alternative instrument for the evaluation of handgrip strength in Duchenne muscular dystrophy
by: Mariana Angélica de Souza, et al.
Published: (2022-06-01)

The role of ataluren in the treatment of ambulatory and non-ambulatory children with nonsense mutation duchenne muscular dystrophy - a consensus derived using a modified Delphi methodology in Eastern Europe, Greece, Israel and Sweden
by: Tanja Golli, et al.
Published: (2024-02-01)

A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy
by: Elisa Domi, et al.
Published: (2021-06-01)

Correlation analysis between cardiac damage and genotype in Duchenne muscular dystrophy
by: Yao ZHANG, et al.
Published: (2015-06-01)